Search

Search Constraints

You searched for: Author/Creator Parks, Stephanie

Search Results

1. DT‐01–06: Baseline FDG‐PET and volumetric MRI predicts Alzheimer's disease conversion from mild cognitive impairment: An ADNI study. (1st July 2013)

2. IC‐O1–01: Pre‐symptomatic functional brain changes in PS1 E280A mutation carriers compared to other biomarkers: Pilot data from the Alzheimer's Prevention Initiative Biomarker project. (1st July 2013)

3. IC‐P‐112: The pattern of cerebral hypometabolism and its association with clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative. (1st July 2013)

4. IC‐P‐155: Association between the Alzheimer's disease‐related hypometabolic convergence index and clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative. (1st July 2013)

5. IC‐P‐156: Association between higher fasting serum glucose levels and the pattern of lower regional gray matter volumes in cognitively normal adults. (1st July 2013)

6. O4–08–01: Association between the Alzheimer's disease–related hypometabolic convergence index and clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative. (1st July 2013)

7. P1–128: Association between higher fasting serum glucose levels and the pattern of lower regional gray matter volumes in cognitively normal adults. (1st July 2013)

8. P1–358: Florbetapir PET, FDG‐PET and MRI in people with Down syndrome with and without symptomatic Alzheimer's disease. (1st July 2013)

9. P3–111: The pattern of cerebral hypometabolism and its association with clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative. (1st July 2013)

10. P4–068: Pre‐symptomatic functional brain changes in PS1 E280A mutation carriers compared with other biomarkers: Pilot data from the Alzheimer's Prevention Initiative Biomarker project. (1st July 2013)